SC 13G/A: Inmune Bio, Inc.
Ticker: INMB · Form: SC 13G/A · Filed: Oct 2, 2024 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | SC 13G/A |
| Filed Date | Oct 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Inmune Bio, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Inmune Bio, Inc. (ticker: INMB) to the SEC on Oct 2, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti).
How long is this filing?
Inmune Bio, Inc.'s SC 13G/A filing is 2 pages with approximately 687 words. Estimated reading time is 3 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 687 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-10-02 16:50:56
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- inmunebioinc-xencorsc13g20.htm (SC 13G/A) — 43KB
- 0001326732-24-000050.txt ( ) — 45KB
(a). Name of Issuer
Item 1(a). Name of Issuer INmune Bio, Inc.
(b). Address of Issuer's Principal Executive Offices
Item 1(b). Address of Issuer's Principal Executive Offices 225 NE Mizner Blvd., Suite 640, Boca Raton, FL 33432
(a). Name of Person Filing
Item 2(a). Name of Person Filing Xencor, Inc. (the "Reporting Person")
(b). Address of Principal Business Office or, if none, Residence
Item 2(b). Address of Principal Business Office or, if none, Residence The address of the principal business office of the Reporting Person is 465 N. Halstead St. Suite 200 Pasadena, California 91107
(c). Citizenship
Item 2(c). Citizenship The Reporting Person is a corporation organized under the laws of the State of Delaware.
(d). Title of Class of Securities
Item 2(d). Title of Class of Securities Common Stock, par value $0.001 per share ("Common Stock")
(e). CUSIP Number
Item 2(e). CUSIP Number 45782T105 Item 3. If this statement is filed pursuant to 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a Not applicable
Ownership
Item 4. Ownership The Reporting Person directly holds 1,885,533 shares of Common Stock. The information required by this item with respect to the Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13GA.
Ownership of 5 Percent or Less of a Class
Item 5. Ownership of 5 Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following .
Ownership of More than 5 Percent on Behalf of Another Person
Item 6. Ownership of More than 5 Percent on Behalf of Another Person Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person Not applicable
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group Not applicable
Notice of Dissolution of a Group
Item 9. Notice of Dissolution of a Group Not applicable
Certifications
Item 10. Certifications Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated October 2, 2024 XENCOR, INC. By s Celia Eckert Celia Eckert General Counsel Corporate Secretary ATTENTION Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)